Cancer immunotherapy drug 'less toxic and prolongs life'

By
Pembrolizumab held advanced head and neck cancers in a group of patients at bay for around two years.
November 23, 2019 at 01:08AM
http://ifttt.com/images/no_image_card.png
READ THE ENTIRE NEWS HERE
DOWNLOAD ALL EAGLES EYES ANDROID APP
Keywords:

No comments:

Post a Comment